Johannes Nagelschmitz

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Johannes Nagelschmitz, Martin Blunck, Joern Kraetzschmar et al. · Clinical Pharmacology Advances and Applications · 2014 · 126 citations · Full text

First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone

Johannes Nagelschmitz, Barbara Voith, Georg Wensing et al. · Antimicrobial Agents and Chemotherapy · 2008 · 95 citations · Full text

Medicinal Chemistry, Allergy, Bay 44-9585 +14

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study

Johannes Nagelschmitz, Stefan Willmann, Heinz Delesen et al. · Clinical Drug Investigation · 2013 · 86 citations · Full text

Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial

Henrik Watz, Johannes Nagelschmitz, Anne Kirsten et al. · Pulmonary Pharmacology & Therapeutics · 2019 · 65 citations

Non-cystic Fibrosis Bronchiectasis, Advanced Lung Disease, Pathology +6

Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study

Boris Weimann, Johannes Nagelschmitz, Claudia Rolinck‐Werninghaus et al. · Clinical Therapeutics · 2013 · 63 citations